1. Garcia M et al. «Global cancer Facts» Figures. Atlanta, GA: American Society, 2007.
2. WHO Cancer Facfs beet № 297, npodateod july 2008. Zast accessed: 24 march 2009.
3. Jones A. O'Brien M, Sommer H et al. Phase II study of oral vinorelbine combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Cancer Chem Pharmacol 2010; 65 (4): 755–63.
4. Tubiana-Mathien N, Bougnoux P, Pecguart D et al. All – oral combination of oral vinorelbine and capecitabine as first – line chemotherapy in Her-2-Ntgative metastatic breast cancer: an Intern. Phase II Trial. Br J Cancer 2009; 101 (2): 232–7.
5. Nole F, Crivellari D, Mattiolin R et al. Phase II study of an-oral combination of vinorelbine with metastatic breast cancer. Cancer Chemother Pharmacol 2009; 4.
6. Finek J, Holubec LiR, Svoboda T et al. A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer. Anticancer Res 2009; 29 (2): 667–70.